ESMO Targeted Anticancer Therapies (TAT) Congress 2026

The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is dedicated to targeted agents for the treatment of cancer and includes topics such as:

• Clinical studies
• Biomarkers
• Drug development methodology
• Drug design
• Immuno-oncology clinical studies
• Genomics and proteomics
• New immunological targets
• Molecular profiling and diagnosis
• Phase 1 studies
• Preclinical drug profiling
• Targeted drug delivery
• Preclinical test models
• Vaccines
• Translational studies
• New molecular targets

Who should Attend

Delegates from industry, academia and governmental agencies with an interest in the development of innovative cancer therapies.